Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $2.26

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $144,703,056

Volume: 0

Performance Metrics

1 Week: 20.21%

1 Month: -0.88%

3 Months: -34.68%

6 Months: -70.88%

1 Year: -65.39%

YTD: -41.60%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

Tonix Pharmaceuticals Holding Corp. (TNXP)

SPDR Dow Jones Industrial Average ETF (DIA)

SPDR Gold Shares (GLD)